Browsing: Clinical

Target for self-developed AI advancement Recruitment of a multi-agency expert evaluation team From the 17th to the 28th, Newgium Lab, a clinical nutrition AI company, will introduce the concept and development direction of the clinical nutrition vertical AI “NUSEUM AI” currently being developed on the first floor of Korea University Guro Hospital’s Future Hall. [NU’EST…

Rare paediatric central nervous system (CNS) tumours comprise a biologically-heterogeneous group of low-incidence diseases that present significant challenges to both therapeutic development and clinical research, limiting the availability of high-quality evidence to guide clinical care. The UK3CR Children’s Cancer Research Group (CRG) CNS Tumours Subgroup convened a multidisciplinary workshop to identify research priorities and establish…

The Lancet Diabetes & Endocrinology Commission redefined obesity by considering both anthropometric and direct measures of adiposity, in addition to body mass index (BMI), and distinguishing preclinical from clinical obesity based on physical function and related conditions. However, the frequency and determinants of progression from preclinical to clinical obesity have never been studied

Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and time considerations

Combined operations deliver unified U.S. and European trial delivery, faster recruitment, and expanded evidence-generation capabilities across pharma, biotech, medtech, diagnostics, and digital health

CINCINNATI (WKRC) – A Cincinnati-based company that began more than 25 years ago is helping drive medical research aimed at giving patients more options while prioritizing safety

The Danish pharmaceutical giant is quietly advancing a fresh weapon in the obesity wars. Novo Nordisk has registered a first-in-human Phase I trial for an undisclosed weight-loss candidate, NNC0721-8060, which will be tested against its own blockbuster semaglutide — the active ingredient behind Wegovy and Ozempic — across 142 participants. The move signals that management…

Many conditions that family physicians manage relate to diet, but connections between specific dietary intakes and health outcomes are often uncertain.1 Generally, controlled dietary research lacks blinding and has poor adherence. Many observational studies of diets face significant confounders and various exposure outliers that change over time

The U.S. Department of Veterans Affairs recently announced that sites in Birmingham and Tuscaloosa will be part of a clinical trial to determine if psilocybin is an effective, safe method to treat depression in veterans

A new partnership between the University of Alaska Anchorage and the Alaska Native Tribal Health Consortium will allow healthcare students to complete their clinical rotations at local ANTHC facilities